Premenstrual Syndrome: Symptomatic and Diagnosed Prevalence, Dualistic Treatment Approach - A Cross-Sectional Study in Ukraine.
Premenstrual Syndrome: Symptomatic and Diagnosed Prevalence, Dualistic Treatment Approach - A Cross-Sectional Study in Ukraine.
复制标题
DOI：
10.4103/ijpvm.ijpvm_18_16
复制
发表时间：
2017
影响因子：
2.1
通讯作者：
Jeannot E
中科院分区：
文献类型：
--
作者：
Crow EM;Jeannot E
经前期综合征（PMS）的诊断和治疗仍然是一个挑战，在常规的医疗实践中，通常侧重于单一的药物治疗。最近的研究表明，包括补充替代医学（CAM）疗法在内的联合治疗可能更有益。本研究的目的是评估诊断和未诊断的PMS/经前焦虑障碍（PMDD）的百分比的基础上存在足够的症状，并比较人群使用激素或药物与CAM治疗。这是一项针对2014年5月至2015年4月在乌克兰进行的160名潜在育龄女性样本人群的横断面研究。根据宣称的症状，29%的女性与26%的先前由医疗专业人员诊断为“中度/重度PMS”，P > 0.05。在30%的人使用药物制剂，主要的副作用，即恶心，失眠，头痛是由止痛药，避孕药，抗抑郁药。只有37.5%的研究人群使用CAM治疗方法来处理PMS症状。其中，22%的患者在长期内症状得到了中度缓解。我们得出的结论是，当处理PMS/PMDD的负担，受影响的寻求治疗的妇女应该有选择和获得各种治疗的综合医学（传统和非传统）。
Diagnosing and treatment of premenstrual syndrome (PMS) still pose a challenge in the routine medical practice which usually focuses on single pharmacological therapy. Recent research suggests that the combination of treatments including complementary alternative medicine (CAM) therapies may be more beneficial. The objective of this study was to assess the percentage of diagnosed and nondiagnosed PMS/premenstrual dysphoric disorder (PMDD) based on the presence of adequate symptoms and to compare population using hormonal or pharmaceutical agents versus CAM therapies. This is a cross-sectional study targeting sample population of 160 females of potentially reproductive age done in Ukraine between May 2014 and April 2015. According to declared symptoms, 29% females versus 26% previously diagnosed by a medical professional qualify for “moderate/severe PMS,” P > 0.05. In 30% persons using pharmacological agents, major side effects, namely, nausea, insomnia, headache was caused by painkillers, contraceptives, and antidepressants. Only 37.5% of study population has been using CAM therapy methods to deal with the symptoms of PMS. Of these, 22% have achieved moderate degree in relief of the symptoms long term. We have concluded that when dealing with the burden of PMS/PMDD, the affected treatment-seeking women should have choice and access to the variety of therapies within integrative medicine (both conventional and nonconventional).